Biote Corp. Files 2025 Proxy Statement
Ticker: BTMD · Form: DEF 14A · Filed: Apr 3, 2025 · CIK: 1819253
| Field | Detail |
|---|---|
| Company | Biote CORP. (BTMD) |
| Form Type | DEF 14A |
| Filed Date | Apr 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Biote Corp DEF 14A filed. Annual meeting May 13th. Vote your shares!
AI Summary
Biote Corp. filed a definitive proxy statement (DEF 14A) on April 3, 2025, for its annual meeting on May 13, 2025. The company, formerly known as Haymaker Acquisition Corp. III, is in the medicinal chemicals and botanical products sector. This filing outlines the agenda and proposals for the shareholder meeting.
Why It Matters
This filing provides shareholders with crucial information regarding the company's governance and voting matters, allowing them to make informed decisions at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual shareholder meeting, not indicating any immediate financial distress or significant operational changes.
Key Numbers
- 0001819253 — Central Index Key (Unique identifier for Biote Corp.)
- 2833 — SIC Code (Industry classification for medicinal chemicals & botanical products)
Key Players & Entities
- Biote Corp. (company) — Registrant
- Haymaker Acquisition Corp. III (company) — Former company name
- 20250403 (date) — Filing date
- 20250513 (date) — Meeting date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit shareholder votes for their annual meetings or other corporate actions, providing detailed information on the matters to be voted upon.
When is Biote Corp.'s annual meeting scheduled?
Biote Corp.'s annual meeting is scheduled for May 13, 2025.
What was Biote Corp.'s former name?
Biote Corp. was formerly known as Haymaker Acquisition Corp. III.
What is Biote Corp.'s primary business sector?
Biote Corp. is classified under MEDICINAL CHEMICALS & BOTANICAL PRODUCTS, with SIC code 2833.
On what date was this proxy statement filed?
This definitive proxy statement was filed on April 3, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 3, 2025 regarding biote Corp. (BTMD).